After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
AMGN belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – General industry. The current market capitalization of AMGEN Inc is $153.42B. A total of 3.8 million shares were traded on the day, compared to an average of 3.70M shares.
In the most recent transaction, Grygiel Nancy A. sold 2,117 shares of AMGN for 313.09 per share on May 03 ’24. After the transaction, the SVP & CCO now owns 9,883 company shares.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. AMGEN Inc pays an annual dividend of $9.00, resulting in a dividend yield of 3.15%, and it has a price to earnings (P/E) ratio of 36.55. AMGN’s most recent ex-dividend date was 3.45% when it declared a $2.38 quarterly dividend that was paid in cash on 2/14/2025. Previously, the company paid the dividend on 11/18/2024 with an ex-dividend date of 2.84%. The AMGN stock dividend was $2.25 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AMGN has a high of $346.85 and a low of $253.30.
As of this writing, AMGN has an earnings estimate of $5.08 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of $5.79 per share and a lower estimate of $4.71.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AMGN’s latest balance sheet shows that the firm has $8.04B in Cash & Short Term Investments as of fiscal 2021. There were $33.31B in debt and $12.18B in liabilities at the time. Its Book Value Per Share was $14.00, while its Total Shareholder’s Equity was $6.70B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMGN is Buy with a score of 3.80.
